A Study to Test How Well Multiple Doses of BI 3810477 Are Tolerated by Healthy Adults
Clinical trial NCT06984926 · COMPLETED
Trial details
- NCT number
- NCT06984926
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-06
- Primary completion
- 2026-03-09
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.